Status:
COMPLETED
Evaluation of an Innovative Speech-enabled Translator in Emergency Settings
Lead Sponsor:
University Hospital, Geneva
Collaborating Sponsors:
University of Geneva, Switzerland
Conditions:
Diagnoses Disease
Eligibility:
All Genders
Brief Summary
Survey-based satisfaction, performance and technical features evaluation of a speech-enabled fixed-phrase translation tool (BabelDR) in an emergency department.
Eligibility Criteria
Inclusion
- As per inclusion criteria, patients were required to have no understanding of French, thus making a diagnostic interview by the doctors impossible.
Exclusion
- Exclusion criteria concerned patients who shared a common language with the doctor and/or were not able to read in their native language.
Key Trial Info
Start Date :
November 29 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 20 2020
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04788966
Start Date
November 29 2018
End Date
January 20 2020
Last Update
March 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of Geneva (HUG)
Geneva, Switzerland, 1205